Medtech industry to work with EMA on notified body role regarding ATMPs
This article was originally published in Clinica
Executive Summary
The European medtech industry association Eucomed says that it is committed to working with the European Medicines Agency’s Committee for Advanced Therapies (CAT) as it drafts guidance for the interaction between notified bodies and the EMA when evaluating ATMPs containing a medical device.